Did you know?
ChinaBio® Group is a consulting and advisory firm helping life science companies and investors achieve success in China. ChinaBio works with U.S., European and APAC companies and investors seeking partnerships, acquisitions, novel technologies and funding in China.
Free Newsletter
Have the latest stories on China's life science industry delivered to your inbox daily or weekly - free!
Free Report
For better result, minimum character length is four(4)
BeiGene of Beijing out-licensed the ex-China rights for a...
Shanghai-based PhageLux has received an investment from...
iKang Healthcare Group, the largest private provider of...
WuXi PharmaTech, the largest China-US CRO, has purchased...
Hainan Haiyao of China will take a 49% position in a $41...
China is Asia’s number one biopharma cluster,...
BVCF, a China private equity growth investor specializing...
WuXi PharmaTech, China’s largest CRO/CMO, announced...
Zhejiang Hisun Pharma will collaborate with Ambrx of San...
WuXi PharmaTech and TaiMed Biologics of Taiwan today...
ChinaBio® News
Greg Scott Interviewed at BIO-Europe Spring
How to bring your China assets to China in 8 minutes
"Mr. Bio in China."
Mendelspod Interview
Multinational pharma held to a higher standard in China
